UK Wants Early Access Scheme To Remain ‘Relevant And Attractive’ Following Brexit

Proposals Aim To Reduce Burden Associated With Collecting Real-World Data

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".